TRIGLYCERIDES ≥150 MG/DL ASSOCIATED WITH GREATER RISK OF CARDIOVASCULAR EVENTS, COSTS AND RESOURCE UTILIZATION IN HIGH-RISK STATIN-TREATED PATIENTS WITH CONTROLLED LOW-DENSITY LIPOPROTEIN CHOLESTEROL: A REAL-WORLD ANALYSIS

Residual CV risk remains despite statin therapy, and high TG are an important CV risk factor. This analysis investigated the real-world impact of high TG on CV outcomes. This retrospective, longitudinal administrative claims analysis of the Optum Research Database included patients aged ≥45 years